Divi’s Labs Q2 Net Profit Soars 35%, Driven by Forex Gains and Strong Revenue

Divi's Labs, a company that makes ingredients for medicines, had a really good quarter from July to September.

They made a lot more money and profit than they did last year, even more than people expected!

A big reason for this was that the money they made from selling things in other countries turned out to be worth more when they changed it back to Indian money, and they also got a special gain from trading money.

They make ingredients for both regular medicines (generics) and special, custom-made medicines for other companies.

The custom-made ones are growing fast because big medicine companies want them.

They are also working on making a lot of special ingredients called peptides, which are used for things like diabetes and cancer.

Even though prices for their regular medicine ingredients are a bit tough, they are good at managing their costs and making sure they have enough supplies.

They are also investing money to build more factories and are expecting even more business from companies that want to make their medicines in different places.